Delcath Systems (DCTH) 1.51 0.01

Delcath Systems, Inc.
(DCTH) 1.51 0.01

Last Trade:	1.50	Day Range:	1.46 - 1.52
Trade Time:	08:05PM	52wk Range:	1.46 - 6.64
Prev. Close:	1.49	Market Cap:	75.24M
Open:	1.51	Div Yield:	0
Volume:	898971	PE:
EPS:	-0.95

The Latest On DCTH

Mid-Day Market Losers 5/25/12 1:08pm

Mid-Day Market Losers 5/25/12 12:17pm

Delcath Prices $20 Million Public Offering of Common Stock and Warrants 5/25/12 8:52am

Delcath Announces Proposed Public Offering Of Common Stock And Warrants 5/24/12 4:28pm

A Peek Into The Market Before The Trading Starts 4/23/12 7:19am

Delcath Systems, Inc. Secures $20 Million Credit Facility 4/23/12 6:39am

A Peek Into The Market Before The Trading Starts 4/10/12 7:18am

Delcath Announces Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training and Launch of Hepatic Chemosat Delivery System 4/10/12 6:36am

Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge 4/5/12 6:39am

A Peek Into The Market Before The Trading Starts 3/27/12 7:19am

Delcath Announces Agreement With Istituto Nazionale Tumori Fondazione G. Pascale for Further Expansion of CHEMOSAT in Italy 3/27/12 6:41am

Delcath Announces First Commercial CHEMOSAT Order in Europe 3/20/12 6:39am

Mid-Day Market Losers 5/25/12

Delcath Prices $20 Million Public Offering of Common Stock and Warrants 5/25/12

Delcath Announces Proposed Public Offering Of Common Stock And Warrants 5/24/12

A Peek Into The Market Before The Trading Starts 4/23/12

Delcath Systems, Inc. Secures $20 Million Credit Facility 4/23/12

A Peek Into The Market Before The Trading Starts 4/10/12

Delcath Announces Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training and Launch of Hepatic Chemosat Delivery System 4/10/12

Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge 4/5/12

A Peek Into The Market Before The Trading Starts 3/27/12

Delcath Announces Agreement With Istituto Nazionale Tumori Fondazione G. Pascale for Further Expansion of CHEMOSAT in Italy 3/27/12

Delcath Announces First Commercial CHEMOSAT Order in Europe 3/20/12

Financial Breakfast: Morning News Summary for February 27, 2012 2/27/12

Weekly Traders Homework: Oil Is The Hot Theme (w/ Economic Calendar and Stock Radar) 2/27/12

Stocks To Watch For January 3 1/3/12

Microcap Movers for Wednesday December 21, 2011 12/21/11

Stocks to Watch for Monday 8/01/2011: Fresh 52 Week Highs and Lows 7/31/11

Stocks to Watch for Friday 7/29/2011: Fresh 52-Week Highs and Lows 7/29/11

Stocks to Watch for Thursday 7/28/2011: Fresh 52 Week Highs and Lows 7/28/11

Mad Money Lightning Round: Cramer Likes Exelixis (HELE, EXEL, DCTH, BKS, AMZN) 4/27/11

Top Percentage Gainers and Losers as of 3:30pm 4/13/11 (ZOOM, GRM, SLGN, DCTH, QTM, IRBT, SIFY, DGW, INVE, YUII, CSR, TRGL, CIGX, MSB, KNDI, CNIT) 4/13/11

Top Percentage Gainers and Losers as of 2pm 4/13/11 (ZOOM, GRM, SLGN, DCTH, SLGN, QTM, NTAP, RVBD, AG, INVE, YUII, CSR, CIGX, MSB, TRGL, STRA) 4/13/11

Mad Money Lightning Round: Cramer Likes Tiffany & Co (VALE, TIF, MOTR, CRUS, ARMH, LVS, DCTH, PCAR, CMI) 2/8/11

Jon Najarian Is Watching Delcath Systems (DCTH) And Savient Pharmaceuticals (SVNT) 10/7/10

Financial Breakfast: Morning News Summary for February 27, 2012 2/27/12

Wedbush Maintains Fair Value Estimate, Rating On DCTH 4/14/11

Wedbush Maintains OP Rating, $16 Fair Value On DCTH 4/12/11

Benzinga’s Volume Movers (GENZ, OSIS, DCTH, ADTN) 5/25/10

Benzinga’s Volume Movers (TZOO, SDXC, IDSA, DCTH, NFLX) 4/26/10

DCTH Initiated With Buy 4/22/10

Stocks That Have Crossed 52-Week Highs (CYBS, DCTH, DISCA, ESCA, FITB) 4/21/10

Trade DCTH
NOW!

Partner Headlines

Delcath Prices Stock and Warrants - Analyst Blog 5/29/12

Delcath Systems Inc. Reports Operating Results (10-K) 3/6/12

BIO CEO Confab Live Blog Replay: Day 2 2/14/12

Timing is Everything: IDCC, DCTH, ACAD 1/18/12

Company News for January 03, 2012 - Corporate Summary 1/3/12

Biotech Stock Mailbag: Mela Sciences 9/9/11

Biotech Calendar: Key Dates for September 8/31/11

Biotech Stock Mailbag: Celsion 5/13/11

Bearish MACD for Delcath Systems - Tale of the Tape 4/28/11

'Mad Money Lightning Round': Go for Exelixis 4/26/11

Biotech Stock Mailbag: Amarin 4/22/11

Delcath: Safety Questions Behind FDA Delay 2/23/11

Press Releases

Delcath To Host Analyst Meeeting 5/30/12 Newswire

Delcath Prices $20 Million Public Offering of Common Stock and Warrants 5/25/12 Newswire

Delcath Announces Proposed Public Offering Of Common Stock And Warrants 5/24/12 Newswire

Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders 5/21/12 Newswire

Delcath Highlights First Quarter 2012 And Recent Accomplishments 5/8/12 Newswire

Delcath To Report Fiscal 2012 First Quarter Results And Conduct Conference Call 5/1/12 Newswire

Low Side Effects Seen in Treatment With Delcath's Second Generation Hemofiltration Cartridge 4/26/12 Newswire

Delcath Systems, Inc. Secures $20 Million Credit Facility 4/23/12 Newswire

Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge 4/13/12 Newswire

/C O R R E C T I O N -- Delcath Systems, Inc./ 4/10/12 Newswire

Delcath Announces Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training and Launch of Hepatic Chemosat Delivery System 4/10/12 Newswire

Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge 4/5/12 Newswire

Get the latest DCTH stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Delcath Systems, Inc. stock price.

Delcath Systems, Inc. by YCharts

Delcath Systems (DCTH) 1.51 0.01

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On DCTH

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social